MedSim and Sonus eye contrast training

Article

Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more

Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more effectively. The two companies are planning to develop a contrast module that will run on MedSim's UltraSim ultrasound training simulator (SCAN Special Report 4/97).

UltraSim enables users to conduct virtual ultrasound exams by scanning a mannequin and accessing ultrasound data stored on CD-ROM that correspond to the area being examined. Sonus hopes an UltraSim contrast module will help the company train large numbers of physicians in the use of its EchoGen contrast agent for echocardiography. The companies plan to conduct a feasibility study on the module at a major U.S. ultrasound teaching institution.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.